Effect of integrated traditional Chinese and Western medicine on 5-year survival of children with malignant solid tumors
ZHANG Ji1 SHI Xue2▲ LI Haitian3 ZHU Xiudan4 TIAN Li5 LIU Zhengmao6
1.Department of Pediatrics, Mentougou District Hospital of Traditional Chinese Medicine in Beijing City, Beijing 102300, China;
2.Department of Traditional Chinese Medicine, National Children′s Medical Center Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China; 3.Department of Rehabilitation, National Children′s Medical Center Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China;
4.Department of Oncology Surgery, National Children′s Medical Center Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China;
5.Department of Pediatrics, Xuanwu Hospital of Traditional Chinese Medicine in Beijing City, Beijing 100053, China; 6.Department of Pediatrics, Xiangyang Traditional Chinese Medicine Hospital, Hubei Province, Xiangyang 441000, China
Abstract：Objective To explore the effect on 5-year survival of integrated traditional Chinese and Western medicine to children with malignant solid tumors. Methods The subjects were 167 children with malignant solid tumors admitted to Beijing Children′s Hospital, Capital Medical University from January 2005 to December 2009, continuous return visit for 5 years, up to January 2015. The children who met the inclusion criteria were divided into treatment group (83 cases) and control group (84 cases) by random number table method. Among them, there were 67 cases in treatment group (16 cases of exfoliation) and 64 cases in control group (20 cases of exfoliation). The treatment group received routine chemotherapy, surgery and traditional Chinese medicine, while the control group received routine chemotherapy and surgery. The survival time, survival and recurrence conditions of two groups were compared. Results The 5-year survival rate was 69.0% in treatment group and 46.7% in control group, there was significant difference in the average survival time between two groups (P ＜ 0.01). There was no significant difference in recurrence rate between two groups (P ＞ 0.05). There was significant difference in disease-free survival between two groups (P ＜ 0.05). Conclusion Fuzheng Jianpi traditional Chinese medicine combined with Western medicine in the treatment of children with solid tumors can successfully complete chemotherapy, prolong the survival time, improve the survival rate and improve the quality of life by reducing adverse reactions of chemotherapy.
张吉1 史学2▲ 李海天3 祝秀丹4 田莉5 刘正茂6. 中西医结合治疗对恶性实体瘤患儿5年生存情况的影响[J]. 中国医药导报, 2019, 16(18): 117-120.
ZHANG Ji1 SHI Xue2▲ LI Haitian3 ZHU Xiudan4 TIAN Li5 LIU Zhengmao6. Effect of integrated traditional Chinese and Western medicine on 5-year survival of children with malignant solid tumors. 中国医药导报, 2019, 16(18): 117-120.
[1] 廖玮玮，何志旭，冉立.1147例儿童实体瘤临床特征分析[J].贵州医科大学学报，2017，42（10）：1227-1232.
[2] 司绍永，仲任，孙立荣，等.伊立替康联合替莫唑胺对儿童难治性实体瘤近期疗效的研究[J].现代生物医学进展，2011，11（15）：2948-2951.
[3] 汤静燕.中国儿童恶性实体瘤诊断与治疗现状[J].中华儿科杂志，2017，55（10）：721-723.
[4] 史学，祝秀丹，王焕民，等.扶正健脾汤结合化疗对实体瘤患儿生活质量及生存期的影响[J].中国中西医结合杂志，2012，32（9）：1175-1179.
[5] 中华医学会儿科学分会血液学组，中国抗癌协会儿科专业委员会.儿童霍奇金淋巴瘤诊疗建议[J].中华儿科杂志，2011，49（3）：186-189.
[6] 中国抗癌协会小儿肿瘤专业委员会，中华医学会小儿外科学分会肿瘤外科学组.儿童神经母细胞瘤诊疗专家共识[J].中华小儿外科杂志，2015，36（1）：3-7.
[7] 中国抗癌协会儿科专业委员会，中华医学会儿科学分会血液学组.儿童霍肾肿瘤多中心协作方案诊治随访报告[J].中华儿科杂志，2016，54（11）：808-813.
[8] 刘正茂，史学.220例化疗中实体瘤患儿的中医辨证分型特点分析[J].北京中医药，2011，30（1）：10-11.
[9] 吴文乾，陈新让，齐林，等.小儿实体肿瘤233例[J].实用儿科临床杂志，2007，22（16）：1273-1276.
[10] Peko JF，Moyen G，Gombe-Mbalawa C. Malignant solid tumours in Brazzaville children：epidemiologieal and anatomopathological aspects [J]. Bull Soc Pathol Exot，2004（2）：117-118.
[11] 顾胜利.小儿腹膜后肿瘤的诊治体会[J].遵义医学院学报，2003，26（3）：268-269.
[12] 陈超，罗意革，董淳强，等.广西小儿恶性实体瘤发病特点及诊断治疗[J].中华实用儿科杂志，2013，28（23）：1805-1807.
[13] 胡嘉健，王焕民.儿童实体瘤的外科治疗[J].中国实用儿科杂志，2018，33（10）：784-787.
[14] 蒋马伟，周仁华，陆冬青，等.儿童实体瘤的放射治疗[J].中国实用儿科杂志，2018，33（10）：787-791.
[15] 王绍钧，王锐，朱冬波.实体瘤靶向药物的研究进展[J].中国药房，2017，28（8）：1149-1152.
[16] Himkawa M，Nishie A，Asayama Y，et al. Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children [J]. Jpn J Radiol，2014，32（9）：529-536.
[17] 乔键，李作青，潘翠玲，等.婴儿期恶性实体瘤诊治特点的临床分析[J].中华小儿外科杂志，2014，35（6）：475-478.
[18] 张谊，张伟令，陈丽萍，等.儿童Ⅳ期肝母细胞瘤52例的临床特点及预后[J].中华实用儿科临床杂志，2015， 30（23）：1809-1811.
[19] 王丽，苏俐，杜茂林，等.恶性肿瘤病人生存质量的研究进展[J].内蒙古医科大学学报，2013，35（4）：321-325.
[20] 范树池，江三红.肿瘤概念的新模式与中医药治疗肿瘤机理的探讨[J].中国医学创新，2012，9（22）：145-146.
[21] Qi F，Zhao L，Zhou A，et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer [J]. Biosci Trends，2015，9（1）：16-34.
2019, Vol. 16 
京公网安备 11010502046598号